Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

ACC 2022: Triple Therapy - When to Use and How Long

ACC 2022 Conference Coverage

D. Kumbhani

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Time to Retire Aspirin?

Top Ten Topics in Clinical Cardiology 2021

R. Mehran

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

The UPSTREAM Management of Aortic Stenosis in the Future

ARCH Advanced Revascularization Symposium

M. Leon

Plant-based Diets for Improving Lipids

National Lipid Association

K. Williams

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

State-of-the-Art, Treatment of Diabetic Kidney Disease (DKD)

Primary Care Education Consortium

S. Brunton

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

Current Status of Prevention and Treatment of Diabetic Nephropathy

George Bakris

Patients in Cardiometabolic Jeopardy: Evolving Strategies for Cardio…

MUSC Cardiology

D. Lloyd-Jones

Use of Finerenone in Patients with Diabetes Who Have Kidney Disease

The Texas Heart Institute

G. Bakris

What's the Ideal Therapy for Obesity?

Stanford Medicine

A. Yeoh

Management of Kidney Health in CKD and DKD: A Cased-Based Multiple-c…

Bijin Thajudeen